Your browser doesn't support javascript.
Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience.
McKay, Siobhan C; Pathak, Samir; Wilkin, Richard J W; Kamarajah, Sivesh K; Wigmore, Stephen J; Rees, Jonathan; Dunne, Declan F J; Garcea, Giuseppe; Ahmad, Jawad; de Liguori Carino, Nicola; Sultana, Asma; Silva, Mike; Lykoudis, Pavlos; Nasralla, David; Milburn, James; Shah, Nehal; Kocher, Hemant M; Bhogal, Ricky; Baron, Ryan D; Navarro, Alex; Halle-Smith, James; Al-Sarireh, Bilal; Sen, Gourab; Jamieson, Nigel B; Briggs, Christopher; Stell, David; Aroori, Somaiah; Bowles, Matthew; Kanwar, Aditya; Harper, Simon; Menon, Krishna; Prachalias, Andreas; Srinivasan, Parthi; Frampton, Adam E; Jones, Claire; Arshad, Ali; Tait, Iain; Spalding, Duncan; Young, Alastair L; Durkin, Damien; Ghods-Ghorbani, Manijeh; Sutcliffe, Robert P; Roberts, Keith J.
  • McKay SC; The Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham, UK; Academic Department of Surgery, University of Birmingham, Birmingham, UK. Electronic address: Siobhan.mckay@uhb.nhs.uk.
  • Pathak S; University Hospitals Bristol NHS Foundation Trust, Bristol, BS2 8HW, UK; Centre for Surgical Research, University of Bristol, Canynge Hall, 39, Whatley Road, Bristol, BS8 2PS, UK. Electronic address: drsamirpathak@gmail.com.
  • Wilkin RJW; Academic Department of Surgery, University of Birmingham, Birmingham, UK. Electronic address: richardwilkin@doctors.net.uk.
  • Kamarajah SK; Department of Hepatobiliary, Pancreatic and Transplant Surgery, The Freeman Hospital, Newcastle Upon Tyne, Tyne and Wear, UK. Electronic address: siveshkk93@gmail.com.
  • Wigmore SJ; Department of Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh, EH16 4SA, UK. Electronic address: s.wigmore@ed.ac.uk.
  • Rees J; University Hospitals Bristol NHS Foundation Trust, Bristol, BS2 8HW, UK. Electronic address: Jonathan.Rees@bristol.ac.uk.
  • Dunne DFJ; Department of Pancreatobiliary Surgery, Royal Liverpool University Hospital, L7 8XP, UK. Electronic address: declan.dunne@rlbuht.nhs.uk.
  • Garcea G; Department of HPB Surgery, University Hospitals of Leicester, Gwendolen Road, Leicester, LE5 4PW, UK. Electronic address: giuseppe.garcea@uhl-tr.nhs.uk.
  • Ahmad J; University Hospitals Coventry and Warwickshire, Clifford Bridge Rd, Coventry, CV2 2DX, UK. Electronic address: jawad.ahmad@uhcw.nhs.uk.
  • de Liguori Carino N; Department of HPB Surgery, Manchester Royal Infirmary, University of Manchester, Manchester, M13 9WL, UK. Electronic address: nicola.deliguoricari0@mft.nhs.uk.
  • Sultana A; Department of HPB Surgery, East Lancashire Teaching Hospitals NHS Trust, Haslingden Road, Blackburn, BB2 3HH, UK. Electronic address: asma.sultana@elht.nhs.uk.
  • Silva M; Oxford University Hospitals NHS FT, Headley Way, Headington, Oxford, OX3 9DU, UK. Electronic address: mikesilva10@gmail.com.
  • Lykoudis P; Hull University Teaching Hospitals, Hull, HU3 2JZ, UK. Electronic address: pavlos.lykoudis@hey.nhs.uk.
  • Nasralla D; Department of HPB Surgery, The Royal Free Hospital, Pond Street, London, NW3 2QG, UK. Electronic address: David.nasralla@nhs.net.
  • Milburn J; HPB Surgical Unit, Aberdeen Royal Infirmary, Aberdeen, AB25 2ZN, UK. Electronic address: j.milburn@nhs.net.
  • Shah N; Department of HPB Surgery. Sheffield University Teaching Hospital. Sheffield, S5 7AU, UK. Electronic address: nehal.shah@nhs.net.
  • Kocher HM; Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK. Electronic address: h.kocher@qmul.ac.uk.
  • Bhogal R; The Royal Marsden Hospital NHS Foundation Trust, Fulham Road, London, SW3 6JJ, UK; Institute for Cancer Research, 123 Old Brompton Road, South Kensington, London, SW7 3RP, UK. Electronic address: ricky.bhogal@rmh.nhs.uk.
  • Baron RD; Department of Pancreatobiliary Surgery, Royal Liverpool University Hospital, L7 8XP, UK. Electronic address: Ryan.baron@liverpoolft.nhs.uk.
  • Navarro A; Nottingham University Hospitals, Derby Rd, Lenton, Nottingham, NG7 2UH, UK. Electronic address: alexnavarro1978@gmail.com.
  • Halle-Smith J; The Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham, UK. Electronic address: James.Halle-Smith@uhb.nhs.uk.
  • Al-Sarireh B; Morriston Hospital, Heol Maes Eglwys, Morriston, Cwmrhydyceirw, Swansea, SA6 6NL, UK. Electronic address: Bilal.al-sarireh@wales.nhs.uk.
  • Sen G; Department of Hepatobiliary, Pancreatic and Transplant Surgery, The Freeman Hospital, Newcastle Upon Tyne, Tyne and Wear, UK. Electronic address: gourab.sen@nhs.net.
  • Jamieson NB; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, 84 Castle St, Glasgow, G4 0SF, UK; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, G61 1BD, UK. Electronic address: nigel.jamieson@glasgow.ac.uk.
  • Briggs C; University Hospitals Plymouth NHS Trust, Derriford Road, Crownhill, Plymouth, Devon, PL6 8DH, UK. Electronic address: christopherbriggs@nhs.net.
  • Stell D; University Hospitals Plymouth NHS Trust, Derriford Road, Crownhill, Plymouth, Devon, PL6 8DH, UK. Electronic address: David.Stell@nhs.net.
  • Aroori S; University Hospitals Plymouth NHS Trust, Derriford Road, Crownhill, Plymouth, Devon, PL6 8DH, UK. Electronic address: Somaiah.Aroori@nhs.net.
  • Bowles M; University Hospitals Plymouth NHS Trust, Derriford Road, Crownhill, Plymouth, Devon, PL6 8DH, UK. Electronic address: Matthew.Bowles@nhs.net.
  • Kanwar A; University Hospitals Plymouth NHS Trust, Derriford Road, Crownhill, Plymouth, Devon, PL6 8DH, UK. Electronic address: Aditya.Kanwar@nhs.net.
  • Harper S; Addenbrookes Hospital, Hills Rd, Cambridge, CB2 0QQ, UK. Electronic address: simon.harper@addenbrookes.nhs.uk.
  • Menon K; King's College Hospital, Denmark Hill, Brixton, London, SE5 9RS, UK. Electronic address: krishna.menon@nhs.net.
  • Prachalias A; King's College Hospital, Denmark Hill, Brixton, London, SE5 9RS, UK. Electronic address: Andreas.Prachalias@nhs.net.
  • Srinivasan P; King's College Hospital, Denmark Hill, Brixton, London, SE5 9RS, UK. Electronic address: Parthi.Srinivasan@nhs.net.
  • Frampton AE; HPB Surgical Unit, Royal Surrey County Hospital NHS Foundation Trust, Guildford, Surrey, GU2 7XX, UK; Department of Clinical and Experimental Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, GU2 7WG, UK. Electronic address: aframpton@nhs.net.
  • Jones C; Mater Hospital, 45-51 Crumlin Rd, Belfast, BT14 6AB, UK. Electronic address: claire.jones@belfasttrust.hscni.net.
  • Arshad A; University Hospital Southampton, Tremona Road, Southampton, Hampshire, SO16 6YD, UK. Electronic address: Ali.Arshad@uhs.nhs.uk.
  • Tait I; Ward 11, Ninewells Hospital and Medical School Dundee, DD1 9SY, UK. Electronic address: itait@nhs.net.
  • Spalding D; Department HPB Surgery, Hammersmith Hospital, DuCane Road, London, W12 0HS, UK; Department of Surgery and Cancer, Imperial College London, London, UK. Electronic address: d.spalding@imperial.ac.uk.
  • Young AL; Department of Pancreatic Surgery, St James's University Hospital, Leeds, LS9 7TF, UK. Electronic address: alistair.young@nhs.net.
  • Durkin D; Royal Stoke NHS Trust, Newcastle Road, Stoke-on-Trent, ST4 6QG, UK. Electronic address: ddurkin@doctors.org.uk.
  • Ghods-Ghorbani M; Academic Department of Surgery, University of Birmingham, Birmingham, UK. Electronic address: Manijeh.Ghods-Ghorbani@uhb.nhs.uk.
  • Sutcliffe RP; The Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham, UK. Electronic address: robert.sutcliffe@uhb.nhs.uk.
  • Roberts KJ; The Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham, UK. Electronic address: Keith.Roberts@uhb.nhs.uk.
HPB (Oxford) ; 23(11): 1656-1665, 2021 11.
Article in English | MEDLINE | ID: covidwho-1525798
ABSTRACT

INTRODUCTION:

The SARS-CoV-2 pandemic presented healthcare providers with an extreme challenge to provide cancer services. The impact upon the diagnostic and treatment capacity to treat pancreatic cancer is unclear. This study aimed to identify national variation in treatment pathways during the pandemic.

METHODS:

A survey was distributed to all United Kingdom pancreatic specialist centres, to assess diagnostic, therapeutic and interventional services availability, and alterations in treatment pathways. A repeating methodology enabled assessment over time as the pandemic evolved.

RESULTS:

Responses were received from all 29 centres. Over the first six weeks of the pandemic, less than a quarter of centres had normal availability of diagnostic pathways and a fifth of centres had no capacity whatsoever to undertake surgery. As the pandemic progressed services have gradually improved though most centres remain constrained to some degree. One third of centres changed their standard resectable pathway from surgery-first to neoadjuvant chemotherapy. Elderly patients, and those with COPD were less likely to be offered treatment during the pandemic.

CONCLUSION:

The COVID-19 pandemic has affected the capacity of the NHS to provide diagnostic and staging investigations for pancreatic cancer. The impact of revised treatment pathways has yet to be realised.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pancreatic Neoplasms / COVID-19 Type of study: Experimental Studies / Observational study Limits: Aged / Humans Country/Region as subject: Europa Language: English Journal: HPB (Oxford) Journal subject: Gastroenterology Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pancreatic Neoplasms / COVID-19 Type of study: Experimental Studies / Observational study Limits: Aged / Humans Country/Region as subject: Europa Language: English Journal: HPB (Oxford) Journal subject: Gastroenterology Year: 2021 Document Type: Article